AIM ImmunoTech Inc.
AIM Real Time Price USDRecent trades of AIM by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by AIM's directors and management
Government lobbying spending instances
-
$40,000 Apr 20, 2022 Issue: Pharmacy Health Issues
-
$40,000 Jan 10, 2022 Issue: Pharmacy Health Issues
-
$40,000 Oct 20, 2021 Issue: Pharmacy Health Issues
-
$40,000 Jul 12, 2021 Issue: Health Issues Pharmacy
-
$30,000 Apr 20, 2021 Issue: Pharmacy Health Issues
-
$30,000 Jan 21, 2021 Issue: Health Issues Pharmacy
-
$30,000 Oct 19, 2020 Issue: Health Issues Pharmacy
-
$30,000 Jul 18, 2020 Issue: Health Issues Pharmacy
Estimated quarterly lobbying spending
New patents grants
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of AIM in WallStreetBets Daily Discussion
Recent insights relating to AIM
Recent picks made for AIM stock on CNBC
ETFs with the largest estimated holdings in AIM
|
Shareholder
|
Shares Held
|
|---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view AIM Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.